Adding targeted radiation to chemotherapy prior to surgery may offer better control of pancreatic tumors—potentially reducing ...

In a small cell therapy trial, 10 out of 12 people with type 1 diabetes no longer needed supplemental insulin, even a year after treatment.

As part of a clinical trial, the National Center for Tumor Diseases (NCT/UCC) Dresden is now offering patients with ...

“Immuneering Reports Positive Overall Survival Data for Atebimetinib (IMM-1-104) from Ongoing Phase 2a Trial in First-Line Pancreatic Cancer Patients.” Press release. Immuneering Corporation. June 17, ...

Based on these encouraging phase 2a data, Immuneering, the company developing atebimetinib, has decided to increase the target enrollment in the first-line pancreatic cancer atebimetinib plus mGnP ...

Vaccines have had a major impact on the control of infectious disease, most recently by helping to combat the COVID-19 pandemic. Prophylactic cancer vaccines have prevented several malignancies by ...

Health Minute” brings original health care and health policy reporting from the KFF Health News newsroom to the airwaves each week.

IMUNON announces promising Phase 1 results for IMNN-101, a DNA plasmid vaccine demonstrating enhanced durability and potential advantages over mRNA vaccines.

The news comes as mRNA vaccines have been targeted by the Trump administration's recent funding cuts, and Health Secretary Robert F. Kennedy Jr. fired all members of the expert vaccine panel the ...

When mRNA is used to create vaccines, mRNA carries instructions into our cells to build proteins that form part of a virus, such as the spike protein of the Covid virus. The body’s cells make these ...

A new kind of mRNA vaccine developed by researchers at the University of Pittsburgh and Penn State University could be cheaper to produce and offer a greater level of immunity across multiple ...